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It is generally believed that transcatheter patent foramen ovale (PFO) closure may not be safely performed due to risk of device thrombosis. Although 
small studies have reported experience with transcatheter PFO closure in patients with thrombophilia, definitive evidence from large studies is still 
lacking.
Methods: We conducted a meta-analysis of outcomes following transcatheter PFO closure among patients with or without hypercoagulable 
thrombophilia. The studies were included if the closure was performed, in atleast 10 patients, for prevention of recurrent neurological events (RNE) 
in people with presumed paradoxical thromboembolism.
Results: We included nine observational studies for review. A total of 161 patients with thrombophilia and 646 without thrombophilia underwent 
PFO closure. The incidence (95% CI) of RNE among the patients with thrombophilia undergoing transcatheter PFO closure was estimated as 0.3 
(0 - 3.2) events per 100 person-years as compared to 1.3 (0 - 2.9) events per 100 person-years. Pooled analysis of comparative estimates failed to 
reveal any significant difference in RNE between the two subgroups [risk difference (95% CI): 0 (-0.04 - 0.03)].
Conclusions: Our meta-analysis fails to demonstrate an increased incidence of RNE after transcatheter PFO closure among patients with 
thrombophilia in comparison to those without thrombophilia.
 
